Enovis CORP (ENOV)
Sector: Healthcare
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country: United States
Exchange: NYSE
Market cap: $1.04B
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
Latest financial period: July 3, 2026
Filed with the SEC: August 6, 2026
Estimated earnings date: November 5, 2026
Profit #1434 of 1484 companies
| | Jul 26 | Apr 26 | Dec 25 | Oct 25 |
|---|
| ROIC | -21.1% | -21.6% | -23.3% | -17.7% |
Growth #729 of 1484 companies
Payout #1117 of 1484 companies
Safety #789 of 1484 companies
Price #1066 of 1484 companies
